SCHEMBL2510193

SCHEMBL2510193

O=C(c1ccc(F)cc1)c1cc2c(ccc3ccccc32)oc1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.65
KDM4E B2RXH2 9/20 0.65
GLA P06280 6/20 0.65
GAA P10253 6/20 0.65
HPGD P15428 5/20 0.65
PPARG P37231 1/20 0.64
MAOB P27338 2/20 0.64
LMNA P02545 1/20 0.62
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
MAPT P10636 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
CASP1 P29466 2/20 0.53
CASP7 P55210 2/20 0.53
HSD17B10 Q99714 2/20 0.53
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
GPR55 Q9Y2T6 1/20 0.50
RUNX1 Q01196 1/20 0.49
CBFB Q13951 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1711024 0.89 ALDH1A1 (0.76) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL2505053 0.88 ALDH1A1 (0.62) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL2510780 0.87 ALDH1A1 (0.65) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL1710778 0.87 MAOB (0.67) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL1710937 0.87 ALDH1A1 (0.65) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL17083907 0.84 PPARG (0.70) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL1711220 0.84 PPARG (0.73) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL2508919 0.80 ALDH1A1 (0.62) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL1711145 0.80 ALDH1A1 (0.62) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL1710766 0.80 ALDH1A1 (0.62) ALDH1A1KDM4EGLAGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344462-B1 PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE UNIV DUNDEE (GB) 2016-05-18 EP disclosed
US-8563557-B2 Pyrimidine derivatives and their pharmaceutical use UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) 2013-10-22 US disclosed
US-20110245282-A1 Compounds University Court of the University of Dundee University Court of the University of St. Andrews 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245282-A1 Compounds NAT1, AR, ARSA ALDH1A1 1954/4885KDM4E 3359/4885GLA 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.